期刊文献+

第二届全国骨肉瘤新辅助化疗专家研讨会会议纪要 被引量:8

原文传递
导出
摘要 1998年9月,《中华骨科杂志》编辑部在北京组织召开了第一届全国骨肉瘤化疗座谈会,邀请了国内十余家医疗单位的从事骨肿瘤临床和基础研究工作的学者,对骨肉瘤化疗的相关问题进行了研讨。那次会议的会议纪要刊登在1999年第1期《中华骨科杂志》上,纪要中推荐了四套化疗方案。经过十年的临床应用,我们认为有必要对这四套方案进行总结、反思和完善,同时系统回顾国内外骨肉瘤新辅助化疗的进展和现状,进一步规范我国骨肉瘤新辅助化疗方案,提高骨肉瘤的治疗水平。
作者 胡永成
出处 《中华骨科杂志》 CAS CSCD 北大核心 2008年第10期870-874,共5页 Chinese Journal of Orthopaedics
  • 相关文献

参考文献16

  • 1胡永成,胡永成.全国骨肉瘤化疗座谈会纪要[J].中华骨科杂志,1999,19(1):7-9. 被引量:56
  • 2Rosen G, Caparros B, Huvos AG, et al. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preop- erative chemotherapy. Cancer, 1982, 49: 1221-1230.
  • 3Bacci G, Forni C, Ferrari S, et al. Neoadjuvant chemotherapy for osteosarcoma of the extremity: intensification of preoperative treatment does not increase the rate of good histologic response to the primary tumor or improve the final outcome. J Pediatr Hematol Oncol, 2003, 25: 845-853.
  • 4Eselgrim M, Grunert H, Kuhne T, et al. Dose intensity of chemotherapy for osteosarcoma and outcome in the Cooperative Osteosarcoma Study Group (COSS) trials. Pediatr Blood Cancer, 2006, 47: 42-50.
  • 5Ferrari S, Palmerini E. Adjuvant and neoadjuvant combination chemotherapy for osteogenic sarcoma. Curr Opin Oncol, 2007, 19: 341-346.
  • 6Bacci G, Loro L, Longhi A, et al. No correlation between methotrexate serum level and histologic response in the pre-operative treatment of extremity osteosarcoma: Anticancer Drugs, 2006, 17: 411-415.
  • 7Goorin AM, Schwartzentruber DJ, Devidas M, et al. Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651. J Clin Oncol, 2003, 21: 1574-1580.
  • 8Bacci G, Ferrari S, Bertoni F, et al. Histologic response of high-grade nonmetastatic osteosarcoma of the extremity to chemotherapy. Clin Orthop Relat Res, 2001, (386): 186-196.
  • 9Maki RG. Gemcitabine and docetaxel in metastatic sarcoma: past, present, and future. Oncologist, 2007, 12: 999-1006.
  • 10Kempf-Bielack B, Bielack SS, Jurgens H, et al. Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS). J Clin Oncol, 2005, 23: 559-568.

共引文献55

同被引文献137

  • 1林峰,陶钧,蔡讯,唐晓春,孙元珏,郭跃武,赵晖,姚阳.大剂量甲氨蝶呤联合顺铂治疗骨肉瘤的临床研究[J].临床肿瘤学杂志,2006,11(1):11-14. 被引量:13
  • 2Link MP,Gebhardt MC,Meyers PA.Osteosarcoma//Pizzo PA,Poplack DG.Principles and Practice of Pediatric Oncology (chap.35).Baltimore,MD:Lippincott Williams and Wilkins,2002:1051-1089.
  • 3Goorin AM,Harris MB,Bemstein M,et al.Phase Ⅱ/Ⅲ trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma:a pediatric oncology group trial.J Clin Oncol,2002,20(2):426-433.
  • 4Saeter G,Hφie J,Stenwig AE,et al.Systemic relapse of patients with osteogenic sarcoma.Prognostic factors for long term survival.Cancer,1995,75(5):1084-1093.
  • 5Thompson RC JR,Cheng EY,Clohisy DR,et al.Results of treatment for metastatic osteosarcoma with neoadjuvant chemotherapy and surgery.Clin Orthop Relat Res,2002(397):240-247.
  • 6Bielack SS,Kempf-Bielack B,Delling G,et al.Prognostic factors in high-grade osteosarcoma of the extremities or trunk:an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols.J Clin Oncol,2002,20(3):776-790.
  • 7Kandioler D,Kromer E,Tüchler H,et al.Long-term results after repeated surgical removal of pulmonary metastases.Ann Thorac Surg,1998,65(4):909-912.
  • 8Pakos EE,Nearchou AD,Grimer RJ,et al.Prognostic factors and outcomes for osteosarcoma:an international collaboration.Eur J Cancer,2009,45(13):2367-2375.
  • 9Picci P.Osteosarcoma (osteogenic sarcoma).Orphanet J Rare Dis,2007,2:6.
  • 10Kempf-Bielack B,Bielack SS,Jürgens H,et al.Osteosarcoma relapse after combined modality therapy:an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS).J Clin Oncol,2005,23(3):559-568.

引证文献8

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部